Malignant urinary system neoplasm
MONDO:0006295A primary or metastatic malignant tumor involving the urinary system. Common tumor types include carcinomas, lymphomas, and sarcomas.
Also known as: cancer of renal system, malignant neoplasm of renal system, malignant renal system neoplasm, malignant urinary system neoplasm, malignant urinary tract neoplasm, renal system cancer, urinary system cancer
4258 clinical trials for this condition and its sub-types, 75 tagged with Malignant urinary system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Malignant urinary system neoplasm
-
Kidney cancer 244 trials · 851 incl. sub-types
8 sub-types
- Renal carcinoma 85 trials · 764 incl. sub-types Sub-types →
- Childhood malignant kidney neoplasm 0 trials · 30 incl. sub-types Sub-types →
- Malignant renal pelvis neoplasm 6 trials · 23 incl. sub-types Sub-types →
- Kidney Wilms tumor 9 trials · 11 incl. sub-types Sub-types →
- Kidney sarcoma 0 trials · 8 incl. sub-types Sub-types →
- Mesoblastic nephroma 4 trials Sub-types →
- Graham-Boyle-Troxell syndrome 0 trials
- Malignant mixed epithelial stromal tumor of the kidney 0 trials
-
Urothelial carcinoma 363 trials · 692 incl. sub-types
5 sub-types
- Bladder transitional cell carcinoma 130 trials · 408 incl. sub-types Sub-types →
- Renal pelvis/ureter urothelial carcinoma 65 trials · 78 incl. sub-types Sub-types →
- Urethra transitional cell carcinoma 17 trials Sub-types →
- Pure squamous carcinoma of the urothelial tract 1 trial
- Non-papillary transitional cell carcinoma of the bladder 0 trials
-
Urinary bladder cancer 39 trials · 682 incl. sub-types
9 sub-types
- Urinary bladder carcinoma 392 trials · 669 incl. sub-types Sub-types →
- Urachus cancer 3 trials · 6 incl. sub-types Sub-types →
- Bladder dome cancer 0 trials Sub-types →
- Bladder lateral wall cancer 0 trials
- Bladder lymphoma 0 trials
- Bladder neck cancer 0 trials
- Bladder sarcoma 0 trials
- Urinary bladder anterior wall cancer 0 trials
- Urinary bladder posterior wall cancer 0 trials
-
Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types
2 sub-types
- Infiltrating bladder urothelial carcinoma 181 trials · 183 incl. sub-types Sub-types →
- Infiltrating renal pelvis/ureter urothelial carcinoma 2 trials Sub-types →
-
Ureter cancer 27 trials · 34 incl. sub-types
3 sub-types
- Ureter carcinoma 1 trial · 19 incl. sub-types Sub-types →
- Ureteral lymphoma 0 trials
- Ureteric orifice cancer 0 trials
-
Urethra cancer 18 trials · 29 incl. sub-types
5 sub-types
- Carcinoma of urethra 2 trials · 21 incl. sub-types Sub-types →
- Anterior urethra cancer 0 trials
- Female urethral cancer 0 trials
- Male urethral cancer 0 trials Sub-types →
- Posterior urethra cancer 0 trials
-
Multiple endocrine neoplasia type 2B 2 trials
-
Malignant prostate phyllodes tumor 0 trials
Most studied deeper sub-types
-
New bladder cancer drug could spare patients from bladder removal
Disease control Not yet recruitingThis Phase 3 trial tests NDV-01, a sustained-release combination of two chemotherapy drugs (gemcitabine and docetaxel), given directly into the bladder. It aims to prevent cancer from coming back in people with non-muscle invasive bladder cancer, including those who have not resp…
Phase 3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis phase 1 trial is evaluating an investigational drug called SI-B036, a bispecific antibody designed to target cancer cells in a unique way. The study will enroll about 30 adults with locally advanced or metastatic urological tumors or other solid tumors. The main goals are to…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New care model aims to close cancer treatment gaps for people with mental illness
Disease control Not yet recruitingThis trial tests a 24-week virtual care program called BRIDGE NET for people with serious mental illness who are starting cancer treatment. The program brings together oncology and mental health teams to plan care, provide early psychiatric support, and regularly check in with pa…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
MRI may replace invasive biopsies for urinary tract cancer diagnosis
Diagnosis Not yet recruitingThis study aims to see if a special MRI scan can accurately diagnose invasive upper urinary tract tumors. About 178 adults with suspicious findings on a CT scan will receive an MRI, and the results will be compared to standard biopsy or follow-up CT. If successful, MRI could offe…
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New program aims to make cancer surgery safer for seniors
Knowledge-focused Not yet recruitingThis study looks at how a special program, called the Geriatric Surgery Verification Program, works at the James Cancer Hospital. The program helps doctors and nurses better care for patients aged 65 and older who need cancer surgery. It includes checking for age-related issues l…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Immunotherapy may change how your body processes other drugs
Knowledge-focused Not yet recruitingThis study will test whether immunotherapy drugs (immune checkpoint inhibitors) change how the liver processes other medications. About 80 adults with various cancers who are starting immunotherapy will take a low-dose cocktail of 7 common drugs. Researchers will measure drug lev…
Early phase 1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC